CBAK Energy wins $96m battery cell order for India EV market

The Dalian-listed lithium-ion manufacturer said the order from an unnamed Indian two- and three-wheeler maker will fill its designated factory to capacity

White and dark grey industrial robotic arms work on a conveyor belt in a brightly lit automated factory with distant storage shelves.

CBAK Energy Technology (NASDAQ: CBAT) has secured a battery cell order valued at approximately US$96 million from an undisclosed Indian manufacturer of electric two- and three-wheelers, the Dalian-based company announced on 25 August. The order is expected to bring CBAK's designated manufacturing facility to full capacity, with delivery scheduled for completion within calendar year 2027.

The Indian customer had previously placed smaller-volume orders with CBAK Energy, and the company says the new contract represents a significant step-up in the commercial relationship. CBAK did not disclose the battery chemistry, cell format, contracted volume in units or megawatt-hours, nor the specific manufacturing site assigned to fulfil the order.

The deal

Chief executive Zhiguang Hu said the scale of the order and the progression from smaller initial contracts reflects the Indian customer's growing confidence in CBAK's manufacturing quality and delivery capabilities. The company added that it is in active discussions with a second, unnamed India-based customer over a further large-volume battery cell order, describing that prospective customer as having historically ranked among its largest. No definitive order has been received from the second party, and CBAK cautioned that no assurance exists that terms will be finalised on the anticipated timeline.

The release is light on financial specifics. CBAK did not disclose a gross-margin profile for the order, the pricing structure, or what share of total group revenues the contract represents. Investors will look to quarterly filings for a cleaner read on the order's earnings contribution.

Market context

India's electric two- and three-wheeler segment is one of the most closely watched emerging markets in global EV supply chains. According to the International Energy Agency's Global EV Outlook 2026, India was the world's second-largest electric two-wheeler market in 2025, with sales of just under 1.3 million units, a 5% year-on-year increase. Electric models accounted for roughly 6% of total two-wheeler sales in the country, a penetration rate that analysts view as pointing to significant long-run growth.

That low penetration makes the segment attractive but also competitively contested. Chinese cell manufacturers, including CATL and BYD's battery unit, have been expanding relationships with South and South-east Asian OEMs as domestic margins compress under overcapacity conditions in China's battery market. For mid-tier NASDAQ-listed producers such as CBAK, a $96 million order from a named market segment carries material significance relative to their balance sheet scale.

The two- and three-wheeler segment also differs technically from passenger EV supply chains. Cells for light electric vehicles (LEVs) typically prioritise cycle life and cost over energy density, which favours lithium iron phosphate (LFP) and, increasingly, sodium-ion chemistries. CBAK's corporate description references both lithium-ion and sodium-ion product lines, though the release does not specify which chemistry underpins this particular order.

Policy read-across

India's EV policy landscape provides the demand-side context. The country's FAME scheme and its successor programmes have targeted two- and three-wheelers as a priority electrification segment, given their dominance in urban transport and their relatively lower cost compared with passenger cars. Localisation requirements under Indian industrial policy create a structural incentive for Indian OEMs to diversify cell sourcing beyond single-country dependency, which CBAK is positioning itself to serve. Separately, any future tightening of India's import duties on Chinese-origin battery cells would represent a risk to the delivery economics of this order, a factor CBAK's forward-looking disclaimer acknowledges under the heading of regulatory and trade risk.